Edition:
United States

ERBA Diagnostics Inc (ERB.A)

ERB.A on American Stock Exchange

0.50USD
28 Jul 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.50
Open
$0.50
Day's High
$0.50
Day's Low
$0.50
Volume
380
Avg. Vol
2,143
52-wk High
$2.22
52-wk Low
$0.50

Latest Key Developments (Source: Significant Developments)

ERBA Diagnostics, Inc. Announces Delay in Filing Quarterly Report on Form 10-Q
Monday, 16 Nov 2015 09:15am EST 

ERBA Diagnostics Inc :Announces delay in filing quarterly report on form 10-q.ERBA Diagnostics has undertaken a review of the intercompany transactions among its subsidiaries.Reviews are on-going,the amounts at issue, which may be material, and the periods to which they relate have not yet been concluded.  Full Article

ERBA Diagnostics entered amended and restated promissory note - Form 8-K
Tuesday, 22 Sep 2015 04:07pm EDT 

ERBA Diagnostics Inc:Entered amended and restated promissory note such that amount of credit facility increased to up to $5 million.  Full Article

ERBA Diagnostics Inc appoints Ernesina Scala as Chief Financial Officer
Wednesday, 6 May 2015 07:00am EDT 

ERBA Diagnostics Inc:Has appointed Ernesina Scala as Chief Financial Officer effective May 1 and Chandra Krishnan as Senior Vice President Global Sales, Marketing and Business Development of ERBA Diagnostics, effective as of April 20.  Full Article

ERBA Diagnostics Inc enters agreement to sell former facilities for $23 mln
Thursday, 26 Mar 2015 08:01am EDT 

ERBA Diagnostics Inc:Announced that its wholly-owned subsidiary - Diamedix Corporation - has entered into a purchase and sale agreement to sell its former facilities located in Miami, Florida, for $23 million.ERBA Diagnostics intends to use the net proceeds from the sale of the property for potential facilities purchases, potential strategic acquisitions and for general working capital.  Full Article

ERBA Diagnostics Inc attains CE Mark for HB Vario A1c detection system and reagents for management of diabetes
Wednesday, 21 Jan 2015 08:00am EST 

ERBA Diagnostics Inc:Has attained CE Mark clearance for HB Vario A1c detection system and associated reagents.Monitoring A1c values can help healthcare providers manage complications from diabetes in patients.CE Mark registration provides marketing authorization in the 28 member states of European Union and can be used for registration in additional countries who recognize CE Mark.  Full Article

BRIEF-ERBA Diagnostics files for non-timely 10-K

* Anticipates filing annual report on form 10-K and quarterly report on form 10-Q for quarter ended September 30, 2015 by May 25 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)